Povidone-Iodine for Surgical Site Infections
Trial Summary
What is the purpose of this trial?
This is a multicenter randomized controlled trial of 1100 patients to evaluate the superiority of combined intraoperative wound irrigation with intraoperative peritoneal lavage with dilute aqueous povidone-iodine compared to normal saline in male and female patients between the ages of 18 and 80 years old undergoing emergency laparotomies with Centers for Disease Control (CDC) class 2 and 3 wounds.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Povidone-Iodine for preventing surgical site infections?
Research shows that povidone-iodine is effective in reducing infections during heart surgeries and is commonly used as a skin antiseptic before surgeries, including cataract operations, due to its strong ability to kill germs. It has been found to be more effective at lower concentrations and is used to clean wounds and surgical sites to prevent infections.12345
Is povidone-iodine safe for use in humans?
Povidone-iodine has been used safely for over ten years in heart surgeries for skin and wound disinfection, with minor wound healing issues in 5% of cases and more serious infections in 0.5% of cases. It is generally considered safe for local antiseptic use, but deep infections can be serious, requiring careful surgical techniques and antibiotics.12467
How is the drug Povidone-Iodine unique for preventing surgical site infections?
Povidone-Iodine (Betadine) is unique because it is an antiseptic that can be used in various concentrations and forms, such as aqueous solutions, to effectively reduce bacteria on the skin and prevent infections. It is known for its excellent microbicidal activity and is less likely to cause skin irritation due to its low free iodine concentration.13489
Research Team
Eligibility Criteria
This trial is for men and women aged 18-80 who are undergoing emergency abdominal surgery (laparotomies) with a moderate to high risk of infection. Participants must have wounds classified as CDC class 2 or 3, indicating some degree of contamination.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo intraoperative peritoneal lavage and wound irrigation with either diluted aqueous povidone-iodine or normal saline during emergency laparotomies
Follow-up
Participants are monitored for safety and effectiveness, including surgical site infections, readmissions, and other complications
Long-term follow-up
Subjects are followed over 18 months to assess long-term outcomes and safety
Treatment Details
Interventions
- Diluted Aqueous Povidone-Iodine (Anti-infective)
Diluted Aqueous Povidone-Iodine is already approved in Canada, Japan, China, Switzerland for the following indications:
- Preoperative skin preparation
- Surgical site infection prevention
- Preoperative skin preparation
- Surgical site infection prevention
- Preoperative skin preparation
- Surgical site infection prevention
- Preoperative skin preparation
- Surgical site infection prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loma Linda University
Lead Sponsor
Adrian Cotton
Loma Linda University
Chief Medical Officer since 2020
MD
Richard H. Hart
Loma Linda University
Chief Executive Officer since 2015
MD, DrPH